查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1605781

臨床風險分組解決方案市場，按組件、應用程式、最終用戶、國家和地區 - 2024-2032年行業分析、市場規模、市場佔有率和預測

Clinical Risk Grouping Solution Market, By Component, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 269 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2023年臨床風險分組解決方案市值為7.049億美元，2024年至2032年年複合成長率為14.10%。

臨床風險分組解決方案市場-市場動態

對高效人口健康管理的需求不斷成長，加上電子健康記錄（EHR）的使用不斷擴大，預計將推動市場成長。

人口健康管理（PHM）的重點是透過解決各種健康決定因素來改善個體群體的健康結果。 EHR 系統的廣泛採用帶來了集中且可存取的患者資料。臨床風險分組解決方案利用這些資料對患者風險進行全面評估，確保醫療保健提供者擁有有效決策所需的資訊。根據美國醫院協會的資料，截至2021年，近五分之四的基層開業醫師（78%）和幾乎所有非聯邦急診醫院（96%）採用了經過認證的EHR。此外，新興經濟體擴大採用數位健康解決方案來改善醫療保健服務，這帶來了巨大的市場機會。然而，資料隱私和安全問題可能會阻礙市場成長。

臨床風險分組解決方案市場 - 關鍵見解

根據研究分析師分享的分析，預計全球市場在預測期內（2024-2032）每年將以 14.10%左右的年複合成長率成長

根據組件細分，預計軟體將在2023年顯示最大的市場佔有率

根據應用細分，人口健康管理是2023年的主導區隔

根據最終用戶細分，醫院和診所行業是2023年的領先組成部分

依地區分類，北美是2023年的主要收入來源

臨床風險分組解決方案市場-細分分析：

全球臨床風險分組解決方案市場根據組件、應用程式、最終用戶和區域進行細分。

市場依組件分為三類：軟體和服務。軟體領域在市場上佔據主導地位。臨床風險分組解決方案市場以目的是評估和管理醫療機構內臨床風險的軟體解決方案為中心。

根據應用，市場分為幾個區隔：人口健康管理、慢性病管理、臨床決策支援、詐欺檢測和預防等。人口健康管理是市場的主導區隔。臨床風險分組解決方案市場逐步與人口健康管理保持一致，因為醫療保健提供者目的是改善患者護理並有效管理人口健康。

根據最終用戶，市場分為兩個主要類別：醫院和診所、門診手術中心、長期照護中心等。醫院和診所行業是市場成長的主要驅動力。該行業經歷擴張，因為它強調透過有效的風險評估和管理來提高患者安全和最佳化臨床護理。

臨床風險分組解決方案市場 - 地理洞察

市場地域廣闊，涵蓋北美、拉丁美洲、歐洲、亞太地區、中東和非洲。這些領域根據對商業活動做出貢獻的國家進一步細分。北美在市場擴張方面處於領先地位，這主要是由於醫療保健 IT 基礎設施投資的增加。美國政府已實施多項措施來改善醫療保健 IT 系統，其中包括《HITECH 法案》，該法案鼓勵醫療保健提供者採用電子健康記錄（EHR）和其他健康 IT 解決方案。這種重視導致了對先進技術的大量投資，例如臨床風險分組解決方案。2021年，美國將國內生產毛額（GDP）的17.8%用於醫療保健，幾乎是經合組織國家平均支出的兩倍。由於人們對慢性病的認知不斷提高，歐洲成為市場成長的第二大地區。

臨床風險分組解決方案市場-競爭格局：

臨床風險分組解決方案市場的競爭日益激烈，許多參與者都致力於提供根據醫療保健提供者的需求量身定做的尖端解決方案。組織對人工智慧和機器學習等先進技術進行大量投資，以提高其風險分組產品的預測功能。這種創新對於維持競爭優勢非常重要。隨著醫療保健格局不斷變化，那些強調創新、互通性和監管合規性，同時有效滿足醫院和診所需求的公司將處於成功的最佳位置。

最新進展：

2021年 4月 1 日，3M 健康資訊系統推出了一個創新技術平台，目的是使醫療保健提供者和付款人能夠致力於被確定為高風險的個人和患者群體的護理優先級和資源分配。

目錄

第1章 臨床風險分組解決方案市場概述

  • 研究範圍
  • 市場預估年份

第2章 執行摘要

  • 市場摘錄
    • 依組件分類的臨床風險分組解決方案市場摘錄
    • 依應用分類的臨床風險分組解決方案市場摘錄
    • 依最終用戶分類的臨床風險分組解決方案市場摘錄
    • 依國家分類的臨床風險分組解決方案市場摘錄
    • 依地區分類的臨床風險分組解決方案市場摘錄
  • 競爭洞察

第3章 臨床風險分組解決方案主要市場趨勢

  • 臨床風險分組解決方案市場促進因素
    • 市場促進因素的影響分析
  • 臨床風險分組解決方案市場限制
    • 市場限制影響分析
  • 臨床風險分組解決方案市場機會
  • 臨床風險分組解決方案市場未來趨勢

第4章 臨床風險分組解決方案產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第5章 臨床風險分組解決方案市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第6章 臨床風險分組解決方案市場格局

  • 2023年臨床風險分組解決方案市佔分析
  • 依主要製造商分類的細分資料
    • 既有參與者分析
    • 新興參與者分析

第7章 臨床風險分組解決方案市場 - 依組件

  • 概述
    • 依組成部分分類的細分市場佔有率分析
    • 軟體
      • 私有雲端
      • 公共雲端
      • 混合雲端
    • 服務

第8章 臨床風險分組解決方案市場 - 依應用

  • 概述
    • 依應用分類的細分市場佔有率分析
    • 人口健康管理
    • 慢性病管理
    • 臨床決策支持
    • 詐欺檢測與預防
    • 其他

第9章 臨床風險分組解決方案市場 - 依最終用戶

  • 概述
    • 依最終用戶分類的細分市場佔有率分析
    • 醫院和診所
    • 門診手術中心
    • 長期照護中心
    • 其他

第10章 臨床風險分組解決方案市場 - 依地理位置

  • 介紹
    • 依地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 臨床風險分組解決方案北美主要製造商
    • 北美市場規模和預測（依國家）
    • 北美市場規模和預測（依組成部分）
    • 北美市場規模和預測（依應用）
    • 北美市場規模和預測（依最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 臨床風險分組解決方案歐洲主要製造商
    • 歐洲市場規模和預測（依國家）
    • 歐洲市場規模和預測（依組成部分）
    • 歐洲市場規模和預測（依應用）
    • 歐洲市場規模和預測（依最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區（APAC）
    • 概述
    • 臨床風險分組解決方案亞太地區主要製造商
    • 亞太地區市場規模與預測（依國家）
    • 亞太地區市場規模和預測（依組成部分）
    • 亞太地區市場規模與預測（依應用）
    • 亞太地區市場規模和預測（依最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 臨床風險分組解決方案拉丁美洲主要製造商
    • 拉丁美洲市場規模與預測（依國家）
    • 拉丁美洲市場規模和預測（依組成部分）
    • 拉丁美洲市場規模與預測（依應用）
    • 拉丁美洲市場規模和預測（依最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 臨床風險分組解決方案中東和非洲主要製造商
    • 中東和非洲市場規模及預測（依國家）
    • 中東和非洲市場規模及預測（依組成部分）
    • 中東和非洲市場規模及預測（依應用）
    • 中東和非洲市場規模和預測（依最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA其他地區

第11章 主要供應商分析 - 臨床風險分組解決方案產業

  • 競爭儀表板
  • 公司簡介
    • 3M Corporation
    • 4S Dawn Clinical Software
    • Apixio
    • Cotiviti Inc.
    • Evolent
    • HBI Solutions
    • Health Catalyst, Inc.
    • HealthEC LLC
    • Lightbeam Health Solutions
    • MedeAnalytics, Inc.
    • Nuance Communications, Inc.
    • Optum, Inc.
    • RELX（LexisNexis Risk Solution）
    • ZeOmega
    • Others

第12章 360 度分析師視角

第13章 附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV4190

REPORT HIGHLIGHT

The Clinical Risk Grouping Solution Market was valued at USD 704.90 million in 2023 and expanded at a CAGR of 14.10% from 2024 to 2032.

A Clinical Risk Grouping Solution represents a structured methodology employed in the healthcare sector to classify patients according to their clinical risks and requirements. This approach assists healthcare professionals in stratifying patients, thereby improving management, resource distribution, and the overall delivery of care. Such solutions are frequently utilized across diverse healthcare environments, including hospitals, managed care organizations, and public health programs, to optimize patient care and enhance operational effectiveness.

Clinical Risk Grouping Solution Market- Market Dynamics

The increasing need for efficient population health management, coupled with the expanding utilization of electronic health records (EHR), is anticipated to propel market growth.

Population health management (PHM) focuses on improving the health outcomes of groups of individuals by addressing various health determinants. The widespread adoption of EHR systems has resulted in centralized and accessible patient data. Clinical Risk Grouping Solutions leverage this data to conduct comprehensive assessments of patient risks, ensuring that healthcare providers have the information needed for effective decision-making. According to the American Hospital Association, as of 2021, nearly 4 in 5 office-based physicians (78%) and nearly all non-federal acute care hospitals (96%) adopted a certified EHR. Furthermore, Emerging economies are increasingly adopting digital health solutions to improve healthcare delivery, which presents significant market opportunities. However, Data Privacy and Security Concerns may hampers the market growth.

Clinical Risk Grouping Solution Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 14.10% over the forecast period (2024-2032)

Based on Component segmentation, software was predicted to show maximum market share in the year 2023

Based on Application segmentation, Population Health Management was the leading Component in 2023

Based on End-User segmentation, Hospitals, and clinics sector was the leading Component in 2023

Based on region, North America was the leading revenue generator in 2023

Clinical Risk Grouping Solution Market- Segmentation Analysis:

The Global Clinical Risk Grouping Solution Market is segmented based on Component, Application, End-User, and Region.

The market is segmented into three categories according to components: software and services. The software segment holds a dominant position in the market. The Clinical Risk Grouping Solution market is centered on software solutions aimed at evaluating and managing clinical risk within healthcare organizations.

The market is categorized into two segments based on application: Population Health Management, Chronic Disease Management, Clinical Decision Support, Fraud Detection and Prevention, and Others. Population Health Management is the leading segment within the market. The Clinical Risk Grouping Solution market is progressively aligning with Population Health Management as healthcare providers aim to improve patient care and effectively manage population health.

The market is classified into two primary categories according to End-User: Hospitals and clinics, Ambulatory surgical centers, Long-term care centers, and others. The Hospitals and clinics sector is the primary driver of market growth. This sector is experiencing expansion as it emphasizes improving patient safety and optimizing clinical care through effective risk assessment and management.

Clinical Risk Grouping Solution Market- Geographical Insights

This market is geographically extensive, encompassing North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These areas are further segmented based on the countries contributing to business activities. North America leads in market expansion, primarily due to increased investments in healthcare IT infrastructure. The U.S. government has implemented several initiatives to improve healthcare IT systems, including the HITECH Act, which encourages healthcare providers to adopt electronic health records (EHRs) and other health IT solutions. This emphasis has resulted in substantial investments in advanced technologies, such as Clinical Risk Grouping Solutions. In 2021, the United States allocated 17.8 percent of its gross domestic product (GDP) to healthcare, nearly double the average expenditure of OECD countries. Europe ranks as the second largest region for market growth, driven by a rising awareness of chronic diseases.

Clinical Risk Grouping Solution Market- Competitive Landscape:

The market for Clinical Risk Grouping Solutions is becoming progressively competitive, with a multitude of participants aiming to deliver cutting-edge solutions tailored to the requirements of healthcare providers. Organizations are making significant investments in advanced technologies, including artificial intelligence and machine learning, to improve the predictive functionalities of their risk grouping offerings. Such innovation is essential for sustaining a competitive edge. As the healthcare landscape continues to transform, those companies that emphasize innovation, interoperability, and regulatory compliance while effectively addressing the demands of hospitals and clinics will be optimally positioned for success.

Recent Developments:

On April 1, 2021, 3M Health Information Systems launched an innovative technology platform designed to enable healthcare providers and payers to focus on care prioritization and resource allocation for individuals and patient groups identified as high-risk.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • 3M Corporation
  • 4S Dawn Clinical Software
  • Apixio
  • Cotiviti Inc.
  • Evolent
  • HBI Solutions
  • Health Catalyst, Inc.
  • HealthEC LLC
  • Lightbeam Health Solutions
  • MedeAnalytics, Inc.
  • Nuance Communications, Inc.
  • Optum, Inc.
  • RELX (LexisNexis Risk Solution)
  • ZeOmega
  • Others

GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET, BY COMPONENT- MARKET ANALYSIS, 2019 - 2032

  • Software
  • Private Cloud
  • Public Cloud
  • Hybrid Cloud
  • Services

GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Population health management
  • Chronic disease management
  • Clinical decision support
  • Fraud detection and prevention
  • Other

GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals & clinics
  • Ambulatory surgical centers
  • Long-term care centers
  • Other

GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Clinical Risk Grouping Solution Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Clinical Risk Grouping Solution Market Snippet by Component
    • 2.1.2. Clinical Risk Grouping Solution Market Snippet by Application
    • 2.1.3. Clinical Risk Grouping Solution Market Snippet by End-User
    • 2.1.4. Clinical Risk Grouping Solution Market Snippet by Country
    • 2.1.5. Clinical Risk Grouping Solution Market Snippet by Region
  • 2.2. Competitive Insights

3. Clinical Risk Grouping Solution Key Market Trends

  • 3.1. Clinical Risk Grouping Solution Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Clinical Risk Grouping Solution Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Clinical Risk Grouping Solution Market Opportunities
  • 3.4. Clinical Risk Grouping Solution Market Future Trends

4. Clinical Risk Grouping Solution Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Clinical Risk Grouping Solution Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Clinical Risk Grouping Solution Market Landscape

  • 6.1. Clinical Risk Grouping Solution Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Clinical Risk Grouping Solution Market - By Component

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Component, 2023 & 2032 (%)
    • 7.1.2. Software
      • 7.1.2.1. Private Cloud
      • 7.1.2.2. Public Cloud
      • 7.1.2.3. Hybrid Cloud
    • 7.1.3. Services

8. Clinical Risk Grouping Solution Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Population health management
    • 8.1.3. Chronic disease management
    • 8.1.4. Clinical decision support
    • 8.1.5. Fraud detection and prevention
    • 8.1.6. Other

9. Clinical Risk Grouping Solution Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 9.1.2. Hospitals & clinics
    • 9.1.3. Ambulatory surgical centers
    • 9.1.4. Long term care centers
    • 9.1.5. Other

10. Clinical Risk Grouping Solution Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Clinical Risk Grouping Solution Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Clinical Risk Grouping Solution Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Clinical Risk Grouping Solution Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Clinical Risk Grouping Solution Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Clinical Risk Grouping Solution Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Clinical Risk Grouping Solution Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. 3M Corporation
    • 11.2.2. 4S Dawn Clinical Software
    • 11.2.3. Apixio
    • 11.2.4. Cotiviti Inc.
    • 11.2.5. Evolent
    • 11.2.6. HBI Solutions
    • 11.2.7. Health Catalyst, Inc.
    • 11.2.8. HealthEC LLC
    • 11.2.9. Lightbeam Health Solutions
    • 11.2.10. MedeAnalytics, Inc.
    • 11.2.11. Nuance Communications, Inc.
    • 11.2.12. Optum, Inc.
    • 11.2.13. RELX (LexisNexis Risk Solution)
    • 11.2.14. ZeOmega
    • 11.2.15. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us